Haleon plc

NYSE:HLN

Drug Manufacturers - Specialty & Generic

Healthcare
$9.08 +0.96%

+$0.08 today

Market cap
$39.85B
Beta
0.25
P/E (TTM)
29.2
EPS (TTM)
$0.11
Dividend yield
2.13%
52W Low $8.65High $11.28

Volume 19.46M

Average 8.79M

HLN Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Haleon plcNYSE: HLN

Net Margin · Q4 FY2025 · quarter ended Dec 2025

Net margin widens to 15.5%

Net margin was 15.5% in Q4 FY2025, up 2.6 pp from a year earlier. On a trailing-twelve-month basis it was 14.6%. Over 3 fiscal years it widened by 5.0 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 12 analysts of 16.7% for the fiscal year ending Dec 2026, up from 14.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
15.5%— QoQ
Last fiscal yearDec 2025
14.8%+1.9 pp YoY
LTMJun 2025
14.6%— YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.6 pp+0.9 pp-1.7 pp
1 year+1.9 pp+1.9 pp-0.1 pp
3 years+5.0 pp+2.9 pp-2.1 pp
5 years+4.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
14.8%
Year-over-year change
+1.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How HLN compares with its peers on the latest reported figures

  • HLN's LTM Jun 2025 net margin of 14.6% is the highest of the 6 companies compared; the peer median is 10.9%.
  • Over three fiscal years its change of +5.0 pp compares with a peer median of -4.1 pp.
HLN Competitors Peer median
Net Margin for HLN and competitors
Company Period LTM level YoY 3-year change
HLNHaleon plcLTM Jun 202514.6% —+5.0 pp
GSKGSK plcLTM Jun 202614.5% +3.7 pp-33.5 pp
CHDChurch & Dwight Co., Inc.LTM Sep 202612.4% -0.3 pp+4.2 pp
KVUEKenvue Inc.LTM Sep 202610.9% +1.3 pp-4.1 pp
CLColgate-Palmolive CompanyLTM Sep 20269.6% -4.8 pp+0.5 pp
PRGOPerrigo Company plcLTM Jun 2026-41.9% -40.0 pp-30.4 pp
Peer median (excluding HLN) 10.9%-0.3 pp-4.1 pp

Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.55B10.86B11.3B11.23B11.03B
Cost of Revenue3.6B4.28B4.34B4.29B3.83B
Gross Profit5.95B6.58B6.96B6.95B6.99B
Gross Margin62.3%60.6%61.6%61.9%63.3%
Research & Development257M300M311M298M308.1M
Selling, General & Admin3.79B4.04B4.29B4.33B4.36B
Operating Expenses4.31B4.75B4.97B4.74B4.43B
Depreciation & Amortization268M287M309M196M352.11M
EBITDA2.21B2.18B2.35B2.51B2.88B
EBITDA Margin23.2%20.1%20.8%22.4%26.1%
Operating Income1.64B1.83B2B2.21B2.41B
Operating Margin17.2%16.8%17.7%19.6%21.9%
Interest Income13M68.98M14M55M76.29M
Interest Expense16M347.36M414M394M332.55M
Other Income / Expenses(2M)(207M)(368M)(296M)(260M)
Income Before Tax1.64B1.62B1.63B1.91B2.15B
Pre-Tax Margin17.1%14.9%14.4%17.0%19.5%
Income Tax Expense197M499M517M435M461.66M
Net Income1.39B1.06B1.05B1.44B1.63B
Net Margin14.6%9.8%9.3%12.8%14.8%
EPS (Basic)0.300.240.240.320.36
EPS (Diluted)0.300.240.240.320.36
Weighted Avg Shares4.62B4.62B4.63B4.57B4.48B
Weighted Avg Shares (Diluted)4.62B4.62B4.63B4.59B4.51B

Haleon plc

NYSE:HLN

Intrinsic Alpha fair value

Locked

Current Price

$9.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.